Qrono Inc. -- Eloquent™

Patients Need Effective Cancer Treatment

Current immunotherapies only help niche patient populations.

Qrono sees hope from an immunoengineering approach.

Learn More

Advancing cancer therapy at the interface of engineering and immunology

Eloquent™ Immunotherapy rewrites tumor-immune cell communication